Patent Cliff Has Drug Companies On Deal Hunt: Report

By Jacqueline Bell (October 27, 2009, 3:50 PM EDT) -- The looming prospect of health care reforms and the upcoming expiration of a number of drug patents by 2012 are fueling consolidation in the pharmaceutical industry, with many more companies pushing to do deals with biotechnology firms that have products in the later stages of development, a new report says....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!